Patent: 5,622,851
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
Summary for Patent: 5,622,851
| Title: | Human deoxycytidylate deaminase gene |
| Abstract: | The present invention is directed to a DNA molecule encoding a gene for human deoxycytidylate deaminase. The DNA molecule comprises 26,764 base pairs. A 1317 base pair 5\' untranslated region is followed by exon 1 of 108 base pairs, which is followed by intron 1 of 402 base pairs, which is followed by exon 2 of 136 base pairs, which is followed by intron 2 of 20,303 base pairs, which is followed by exon 3 of 117 base pairs, which is followed by intron 3 of 1357 base pairs, which is followed by exon 4 of 97 base pairs, which is followed by intron 4 of 1554 base pairs, which is followed by exon 5 of 76 base pairs, which is followed by a 3\' untranslated region of 1297 base pairs. Methods of using the DNA molecule are also provided. |
| Inventor(s): | Maley; Frank (Delmar, NY), Maley; Gladys R. (Delmar, NY), Weiner; Karen X. B. (Syracuse, NY) |
| Assignee: | Health Research, Incorporated (Albany, NY) |
| Application Number: | 08/370,975 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,622,851
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Sign Up | 2039-02-26 |
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Sign Up | 2039-02-26 | |
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Sign Up | 2039-02-26 | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
